Compare INFU & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | FOCL |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | France |
| Employees | N/A | 289 |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 203.7M |
| IPO Year | 2005 | N/A |
| Metric | INFU | FOCL |
|---|---|---|
| Price | $9.19 | $6.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 245.3K | 43.1K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $3.20 | N/A |
| Revenue Next Year | $7.31 | N/A |
| P/E Ratio | $177.80 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $5.43 | $4.76 |
| 52 Week High | $11.04 | $6.18 |
| Indicator | INFU | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 85.41 |
| Support Level | $8.51 | $5.30 |
| Resistance Level | $10.04 | N/A |
| Average True Range (ATR) | 0.37 | 0.20 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 36.52 | 82.83 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.